Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Shares Outstanding (Weighted Average) (2019 - 2025)

P3 Health Partners (PIII) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $3.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 0.93% year-over-year to $3.3 million, compared with a TTM value of $3.3 million through Sep 2025, up 0.93%, and an annual FY2024 reading of $145.2 million, changed N/A over the prior year.
  • Shares Outstanding (Weighted Average) was $3.3 million for Q3 2025 at P3 Health Partners, roughly flat from $3.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $145.2 million in Q4 2024 and bottomed at $2.4 million in Q1 2024.
  • Average Shares Outstanding (Weighted Average) over 5 years is $35.4 million, with a median of $31.6 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Weighted Average) soared 328.86% in 2022, then plummeted 96.34% in 2024.
  • Year by year, Shares Outstanding (Weighted Average) stood at $27.3 million in 2021, then surged by 52.05% to $41.6 million in 2022, then soared by 111.67% to $88.0 million in 2023, then surged by 64.95% to $145.2 million in 2024, then crashed by 97.75% to $3.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for PIII at $3.3 million in Q3 2025, $3.3 million in Q2 2025, and $3.3 million in Q1 2025.